Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Sell
50
GKOS Quote, Financials, Valuation and Earnings
Last price:
$151.60
Seasonality move
:
12.09%
Day range:
$149.28 - $151.92
52-week range:
$76.25 - $153.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21.46x
P/B ratio:
12.49x
Volume:
372.4K
Avg. volume:
566.3K
1-year change:
98.23%
Market cap:
$8.4B
Revenue:
$314.7M
EPS (TTM):
-$2.96
Analysts' Opinion
-
Consensus RatingGlaukos has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $154.58, Glaukos has an estimated upside of 2.07% from its current price of $151.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $120.00 representing 20.77% downside risk from its current price of $151.45.
Fair Value
-
According to the consensus of 11 analysts, Glaukos has 2.07% upside to fair value with a price target of $154.58 per share.
GKOS vs. S&P 500
-
Over the past 5 trading days, Glaukos has underperformed the S&P 500 by -0.33% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Glaukos does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Glaukos has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Glaukos reported revenues of $96.7M.
Earnings Growth
-
Glaukos has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Glaukos reported earnings per share of -$0.39.
Enterprise value:
8.1B
EV / Invested capital:
--
Price / LTM sales:
21.46x
EV / EBIT:
--
EV / Revenue:
22.60x
PEG ratio (5yr expected):
-5.10x
EV / Free cash flow:
-100.22x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$276.1M
Return On Assets:
-16.02%
Net Income Margin (TTM):
-41.51%
Return On Equity:
-27.46%
Return On Invested Capital:
-20.29%
Operating Margin:
-25.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $284.9M | $303.6M | $360.3M | $78M | $96.7M | |
| Gross Profit | $216.3M | $229.7M | $276.1M | $59.5M | $74.1M | |
| Operating Income | -$86.4M | -$120.8M | -$116.1M | -$28M | -$24.7M | |
| EBITDA | -$40.3M | -$77M | -$97M | -$15.3M | -$7.4M | |
| Diluted EPS | -$1.90 | -$2.69 | -$2.96 | -$0.63 | -$0.39 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $454.4M | $501.8M | $448.8M | $399.5M | $397.3M | |
| Total Assets | $994.5M | $1.1B | $1B | $948.6M | $926.5M | |
| Current Liabilities | $46.7M | $63.5M | $60.6M | $67.1M | $71.7M | |
| Total Liabilities | $333M | $463.1M | $459.9M | $471M | $258M | |
| Total Equity | $661.6M | $601M | $548.6M | $477.7M | $668.5M | |
| Total Debt | $186.7M | $279.7M | $281.1M | $282.4M | $56.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$33.6M | -$51.2M | -$72.5M | -$8.2M | -$9.6M | |
| Cash From Investing | $19.3M | $43.7M | $23.1M | $14.9M | $30.6M | |
| Cash From Financing | $7.3M | $8.3M | $38.7M | $7.5M | $9.7M | |
| Free Cash Flow | -$65M | -$75.5M | -$81.3M | -$11.5M | -$11M | |
GKOS
Sector
Market Cap
$8.4B
$49.2M
Price % of 52-Week High
98.66%
48.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
98.23%
-30.94%
Beta (5-Year)
1.041
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$150.50
200-day SMA
Buy
Level
$121.79
Bollinger Bands (100)
Buy
Level
126.6 - 142.78
Chaikin Money Flow
Buy
Level
54.5M
20-day SMA
Buy
Level
$145.37
Relative Strength Index (RSI14)
Buy
Level
60.39
ADX Line
Buy
Level
14.68
Williams %R
Sell
Level
-12.8931
50-day SMA
Buy
Level
$141.03
MACD (12, 26)
Buy
Level
3.19
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
66.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.326)
Sell
CA Score
(Annual)
Level (-0.8476)
Buy
Beneish M-Score
(Annual)
Level (-2.8011)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.835)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Stock Forecast FAQ
In the current month, GKOS has received 8 Buy ratings 2 Hold ratings, and 1 Sell ratings. The GKOS average analyst price target in the past 3 months is $154.58.
-
Where Will Glaukos Stock Be In 1 Year?
According to analysts, the consensus estimate is that Glaukos share price will rise to $154.58 per share over the next 12 months.
-
What Do Analysts Say About Glaukos?
Analysts are divided on their view about Glaukos share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Glaukos is a Sell and believe this share price will drop from its current level to $120.00.
-
What Is Glaukos's Price Target?
The price target for Glaukos over the next 1-year time period is forecast to be $154.58 according to 11 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is GKOS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Glaukos is a Buy. 8 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GKOS?
You can purchase shares of Glaukos via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Glaukos shares.
-
What Is The Glaukos Share Price Today?
Glaukos was last trading at $151.60 per share. This represents the most recent stock quote for Glaukos. Yesterday, Glaukos closed at $151.45 per share.
-
How To Buy Glaukos Stock Online?
In order to purchase Glaukos stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
How High Can Palantir Stock Go?
Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
